Bristol-Myers Squibb Company (BMY) to Divest 60% China JV Amid Strategic Realignment
Bristol-Myers SquibbBristol-Myers Squibb(US:BMY) Yahoo Finance·2025-09-23 23:02

In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Bristol-Myers Squibb Company is placed third among them. Bristol-Myers Squibb Company (NYSE:BMY), a global biopharmaceutical leader in oncology, immunology, cardiovascular disease, and fibrosis, is undergoing major strategic changes as it adapts to shifting market conditions. On September 17, 2025, the company announced plans to divest its 60% stake in a pharmaceutical joint venture in China. The move ...